Used in the management of acute coronary syndrome to prevent blood clots during percutaneous coronary interventions. It works by inhibiting platelet aggregation, reducing the risk of thrombotic complications such as heart attack or stroke. Commonly administered intravenously in hospital settings, especially during angioplasty or stent placement, to maintain blood flow in coronary arteries. Its short half-life allows for quick onset and offset of action, enabling precise control during procedures.